Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in thousands)
| 10-1999 | 10-1998 | |
| Cash Flows From Operating Activities | ||
| Depreciation Amortization | 200 | 200 |
| Other Operating Activity | -800 | -100 |
| Operating Cash Flow | $-600 | $100 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -200 | N/A |
| Other Investing Activity | 100 | 0 |
| Investing Cash Flow | $-100 | $0 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 600 | 100 |
| Other Financing Activity | -200 | 200 |
| Financing Cash Flow | $400 | $300 |
| Beginning Cash Position | 300 | 0 |
| End Cash Position | 0 | 300 |
| Net Cash Flow | $-300 | $400 |
| Free Cash Flow | ||
| Operating Cash Flow | -600 | 100 |
| Capital Expenditure | -200 | N/A |
| Free Cash Flow | -800 | 100 |